Biodesix is more accurately categorized as a data-driven diagnostic solutions company rather than a traditional medical device manufacturer, though it operates heavily within the broader life sciences, healthcare, and biotechnology sectors. The organization focuses primarily on the discovery, development, and commercialization of novel diagnostic tests that utilize blood-based molecular assays, genomic sequencing, and advanced machine learning algorithms. Their core mission centers on addressing critical unmet needs in oncology, particularly lung cancer management, by providing physicians with actionable genomic insights and blood-based diagnostic tools. Rather than producing physical medical hardware or surgical devices, Biodesix operates specialized clinical laboratories that process patient blood samples to deliver high-complexity molecular diagnostics. These tests help healthcare providers determine the most effective therapeutic strategies, monitor treatment response, and detect disease recurrence early. Therefore, while their products and services directly impact patient care in clinical medical settings, they are fundamentally a diagnostic services and biotechnology firm specializing in molecular testing rather than a conventional medical device maker.